157 related articles for article (PubMed ID: 23065496)
1. Obstetric nephrology: preeclampsia--the nephrologist's perspective.
Umans JG
Clin J Am Soc Nephrol; 2012 Dec; 7(12):2107-13. PubMed ID: 23065496
[TBL] [Abstract][Full Text] [Related]
2. Explaining and predicting preeclampsia.
Lindheimer MD; Umans JG
N Engl J Med; 2006 Sep; 355(10):1056-8. PubMed ID: 16957153
[No Abstract] [Full Text] [Related]
3. Soluble fms-like tyrosine kinase-1 and soluble endoglin in HIV-associated preeclampsia.
Govender N; Naicker T; Rajakumar A; Moodley J
Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):100-5. PubMed ID: 23806447
[TBL] [Abstract][Full Text] [Related]
4. Angiogenic biomarkers for prediction of early preeclampsia onset in high-risk women.
Moore Simas TA; Crawford SL; Bathgate S; Yan J; Robidoux L; Moore M; Maynard SE
J Matern Fetal Neonatal Med; 2014 Jul; 27(10):1038-48. PubMed ID: 24066977
[TBL] [Abstract][Full Text] [Related]
5. Added value of angiogenic factors for the prediction of early and late preeclampsia in the first trimester of pregnancy.
Crovetto F; Figueras F; Triunfo S; Crispi F; Rodriguez-Sureda V; Peguero A; Dominguez C; Gratacos E
Fetal Diagn Ther; 2014; 35(4):258-66. PubMed ID: 24714555
[TBL] [Abstract][Full Text] [Related]
6. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.
Levine RJ; Lam C; Qian C; Yu KF; Maynard SE; Sachs BP; Sibai BM; Epstein FH; Romero R; Thadhani R; Karumanchi SA;
N Engl J Med; 2006 Sep; 355(10):992-1005. PubMed ID: 16957146
[TBL] [Abstract][Full Text] [Related]
7. Angiogenic biomarkers in pregnancy: defining maternal and fetal health.
Rasmussen LG; Lykke JA; Staff AC
Acta Obstet Gynecol Scand; 2015 Aug; 94(8):820-32. PubMed ID: 25753566
[TBL] [Abstract][Full Text] [Related]
8. Effective prediction of preeclampsia by a combined ratio of angiogenesis-related factors.
Lim JH; Kim SY; Park SY; Yang JH; Kim MY; Ryu HM
Obstet Gynecol; 2008 Jun; 111(6):1403-9. PubMed ID: 18515525
[TBL] [Abstract][Full Text] [Related]
9. Emerging new biomarkers of preeclampsia.
Polsani S; Phipps E; Jim B
Adv Chronic Kidney Dis; 2013 May; 20(3):271-9. PubMed ID: 23928393
[TBL] [Abstract][Full Text] [Related]
10. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension.
Noori M; Donald AE; Angelakopoulou A; Hingorani AD; Williams DJ
Circulation; 2010 Aug; 122(5):478-87. PubMed ID: 20644016
[TBL] [Abstract][Full Text] [Related]
11. Levels of antiangiogenic factors in preeclamptic pregnancies.
Zhao W; Qiao J; Zhang Q; Zhao Y; Chen Q
Growth Factors; 2010 Aug; 28(4):293-8. PubMed ID: 20214506
[TBL] [Abstract][Full Text] [Related]
12. Endoglin, PlGF and sFlt-1 as markers for predicting pre-eclampsia.
De Vivo A; Baviera G; Giordano D; Todarello G; Corrado F; D'anna R
Acta Obstet Gynecol Scand; 2008; 87(8):837-42. PubMed ID: 18607829
[TBL] [Abstract][Full Text] [Related]
13. A report from #BlueJC: Can measuring angiogenic factors help with predicting preterm pre-eclampsia in low-risk women?
Black M; Leung EY
BJOG; 2014 Feb; 121(3):375. PubMed ID: 24428457
[No Abstract] [Full Text] [Related]
14. Angiogenic factors combined with clinical risk factors to predict preterm pre-eclampsia in nulliparous women: a predictive test accuracy study.
Thornton J
BJOG; 2014 Mar; 121(4):507. PubMed ID: 24533478
[No Abstract] [Full Text] [Related]
15. Gestational angiogenic biomarker patterns in high risk preeclampsia groups.
Maynard SE; Crawford SL; Bathgate S; Yan J; Robidoux L; Moore M; Moore Simas TA
Am J Obstet Gynecol; 2013 Jul; 209(1):53.e1-9. PubMed ID: 23517919
[TBL] [Abstract][Full Text] [Related]
16. Authors' reply: Angiogenic factors combined with clinical risk factors to predict preterm pre-eclampsia in nulliparous women: a predictive test accuracy study.
Myers JE; Kenny LC; McCowan LM; Chan EH; Dekker GA; Poston L; Simpson NA; North RA;
BJOG; 2014 Mar; 121(4):507. PubMed ID: 24533477
[No Abstract] [Full Text] [Related]
17. Soluble endoglin for the prediction of preeclampsia in a high risk cohort.
Maynard SE; Moore Simas TA; Bur L; Crawford SL; Solitro MJ; Meyer BA
Hypertens Pregnancy; 2010; 29(3):330-41. PubMed ID: 20670156
[TBL] [Abstract][Full Text] [Related]
18. Serum sFlt1:PlGF ratio, PlGF, and soluble endoglin levels in gestational proteinuria.
Ohkuchi A; Hirashima C; Matsubara S; Suzuki H; Takahashi K; Usui R; Suzuki M
Hypertens Pregnancy; 2009 Feb; 28(1):95-108. PubMed ID: 19165674
[TBL] [Abstract][Full Text] [Related]
19. Modification of angiogenic factors by regular and acute exercise during pregnancy.
Weissgerber TL; Davies GA; Roberts JM
J Appl Physiol (1985); 2010 May; 108(5):1217-23. PubMed ID: 20224004
[TBL] [Abstract][Full Text] [Related]
20. Circulating angiogenic and antiangiogenic factors in women with eclampsia.
Vaisbuch E; Whitty JE; Hassan SS; Romero R; Kusanovic JP; Cotton DB; Sorokin Y; Karumanchi SA
Am J Obstet Gynecol; 2011 Feb; 204(2):152.e1-9. PubMed ID: 21062661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]